| 产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
|---|---|---|---|---|
| A998781 | Anti-ICAM1 / CD54 Reference Antibody (bersanlimab), Anti-ICAM1 / CD54 Reference Antibody (bersanlimab), |
|||
| A998782 | Anti-ICAM3 / CD50 Reference Antibody (Forerunner patent anti-ICAM-3), Anti-ICAM3 / CD50 Reference Antibody (Forerunner patent anti-ICAM-3), |
|||
| A998783 | Anti-ICOS / CD278 Reference Antibody (alomfilimab), Anti-ICOS / CD278 Reference Antibody (alomfilimab), |
|||
| A998784 | Anti-ICOS / CD278 Reference Antibody (feladilimab), Anti-ICOS / CD278 Reference Antibody (feladilimab), |
|||
| A998785 | Anti-ICOS / CD278 Reference Antibody (MEDI-570), Anti-ICOS / CD278 Reference Antibody (MEDI-570), |
|||
| A998786 | Anti-ICOS / CD278 Reference Antibody (vopratelimab), Anti-ICOS / CD278 Reference Antibody (vopratelimab), |
|||
| A998787 | Anti-IDO2 Reference Antibody (LIMR patent anti-IDO2), Anti-IDO2 Reference Antibody (LIMR patent anti-IDO2), |
|||
| A998788 | Anti-IFNa1 Reference Antibody (Baylor patent anti-IFN alpha), Anti-IFNa1 Reference Antibody (Baylor patent anti-IFN alpha), |
|||
| A998789 | Anti-IFNa1 Reference Antibody (Chinese CDC patent anti-Interferon Alpha), Anti-IFNa1 Reference Antibody (Chinese CDC patent anti-Interferon Alpha), |
|||
| A998790 | Anti-IFNa1 Reference Antibody (rontalizumab), Anti-IFNa1 Reference Antibody (rontalizumab), |
|||
| A998791 | Anti-IFNa1 Reference Antibody (sifalimumab), Anti-IFNa1 Reference Antibody (sifalimumab), |
|||
| A998792 | Anti-IFNAR1 Reference Antibody (anifrolumab), Anti-IFNAR1 Reference Antibody (anifrolumab), |
|||
| A998793 | Anti-IFNAR1 Reference Antibody (Medarex patent anti-IFNAR-1), Anti-IFNAR1 Reference Antibody (Medarex patent anti-IFNAR-1), |
|||
| A998794 | Anti-IFNg Reference Antibody (AMG 811), Anti-IFNg Reference Antibody (AMG 811), |
|||
| A998795 | Anti-IFNg Reference Antibody (emapalumab), Anti-IFNg Reference Antibody (emapalumab), |
|||
| A998796 | Anti-IFNg Reference Antibody (fontolizumab), Anti-IFNg Reference Antibody (fontolizumab), |
|||
| A998797 | Anti-IgE (M1 prime) Reference Antibody (quilizumab), Anti-IgE (M1 prime) Reference Antibody (quilizumab), |
|||
| A998798 | Anti-IgE Reference Antibody (ligelizumab), Anti-IgE Reference Antibody (ligelizumab), |
|||
| A998799 | Anti-IgE Reference Antibody (omalizumab), Anti-IgE Reference Antibody (omalizumab), |
|||
| A998800 | Anti-IgE Reference Antibody (talizumab), Anti-IgE Reference Antibody (talizumab), |